Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Small molecule screen reveals pathways that regulate C4 secretion in stem-cell derived astrocytes.

ABSTRACT: Small molecule screen reveals pathways that regulate C4 secretion in stem-cell derived astrocytes.

PROVIDER: PRJNA880585 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR21573600.fastq.gz	Fastqsanger.gz
	SRR21573601.fastq.gz	Fastqsanger.gz
	SRR21573602.fastq.gz	Fastqsanger.gz
	SRR21573603.fastq.gz	Fastqsanger.gz
	SRR21573604.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 95

Similar Datasets

Small molecule screen reveals pathways that regulate C4 secretion in stem-cell derived astrocytes.

Project description:In the brain, the complement system plays a crucial role in the immune response and in synaptic elimination during normal development and disease. Here, we sought to identify pathways that modulate the production of complement component 4 (C4), recently associated with an increased risk of schizophrenia. To design a disease-relevant assay, we first developed a rapid and robust 3D protocol capable of producing large numbers of astrocytes from pluripotent cells. Transcriptional profiling of these astrocytes confirmed the homogeneity of this population of dorsal fetal-like astrocytes. Using a novel ELISA-based small molecule screen, we identified epigenetic regulators, as well as inhibitors of intracellular signaling pathways, able to modulate C4 secretion from astrocytes. We then built a Connectivity Map to predict and validate additional key regulatory pathways, including one involving c-Jun-kinase (JNK). This work provides a foundation for developing therapies for CNS diseases involving the complement cascade.

2022-09-17 | GSE213352 | GEO

A novel phenotypic drug screen identifies potent inhibitors of mycobacterial virulence protein secretion

Project description:Mycobacterium tuberculosis (Mtb) depends on protein secretion systems for intracellular survival and virulence. The major virulence determinant and ESX-1 dependent effector protein EsxA causes tissue damage and necrosis which promotes spread and dissemination of the bacterium. We developed a fibroblast survival assay (FSA) that exploits this phenotype by selecting for molecules that protect host cells from Mtb-induced lysis. Hit compounds identified in this high-throughput screen blocked the secretion of EsxA thus promoting phagosome maturation which led to substantially reduced bacterial burden in activated macrophages. Target identification studies performed on these drugs led to discovery of a benzothiophene containing histidine kinase inhibitor and a benzyloxybenzylidine hydrazine compound affecting mycobacterial metal ion homeostasis which enabled us to reveal zinc stress as a signal for EsxA secretion. Collectively, this novel drug screening approach can help to tackle the mounting problem of antibiotic-resistant mycobacteria by largely extending the target spectrum of small molecule libraries.

2015-05-15 | GSE58314 | GEO

Cellular active small molecule inhibitors of Mycobacterium tuberculosis by NMR fragment screen

Project description:Cellular active small molecule inhibitors of Mycobacterium tuberculosis by NMR fragment screen.

2015-01-01 | GSE17424 | GEO

A human tissue screen identifies a regulator of ER secretion as a brain size determinant [organoid - screen]

Project description:A human tissue screen identifies a regulator of ER secretion as a brain size determinant [organoid - screen]

| PRJNA635649 | ENA

Expression data from prostate cancer cell lines C4-2B (enzalutamide sensitive) and C4-2B-MDVR (enzalutamide resistant) cells

Project description:Prostate cancer C4-2B cells were cultured in enzalutamide in a dose-escalation manner. After sixty passages cells were resistant to enzalutamide, with a specific sets of genes been deregulated. We performed global gene expression analysis by cDNA microarrays to identify genes responsible for enzalutamide resistance in C4-2B-MDVR cells. Enzalutamide resistant C4-2B-MDVR cells were selected from C4-2B cells during long time enzalutamide treatment. Genes responsible for enzalutamide resistance were identified using C4-2B vs. C4-2B-MDVR RNA extraction and hybridization on Affymetrix microarrays.

2015-04-09 | E-GEOD-64143 | biostudies-arrayexpress

Gene expression in the development of C3 and C4 Atriplex and C3 Atriplex prostrata x C4 Atriplex rosea F1 hybrids

Project description:Elucidating the genetic control of development of C3 and C4 photosynthesis. Atriplex rosea (C4) and Atriplex prostrata (C3) were studied along a leaf developmental gradient to compare development between C3 and C4. C3 Atriplex prostrata x C4 Atriplex rosea F1 hybrid were studied along the same developmental gradient and will aid in identifying regulatory elements involved in C3 and C4 leaf development.

2023-01-01 | GSE89920 | GEO

Small molecule screen identifies de novo nucleotide synthesis as a vulnerability of cells lacking SIRT3

Project description:Sirtuin 3 (SIRT3) is an NAD+-dependent deacetylase downregulated in aging and age-associated diseases such as cancer and neurodegeneration, and high fat diet (HFD)-induced metabolic disorders. Thus, we performed a small molecule screen and identified an unexpected metabolic vulnerability associated with SIRT3 loss.

2018-01-18 | GSE109279 | GEO

High-Throughput Screen Identifies Non-Inflammatory Small Molecule Inducers of Trained Immunity

Project description:High-Throughput Screen Identifies Non-Inflammatory Small Molecule Inducers of Trained Immunity

| PRJNA1127561 | ENA

Project description:C4

| OEX00016358 | NODE

A genetic screen identifies hypothalamic Fgf15/19 as a regulator of glucagon secretion

Project description:The counterregulatory response to hypoglycemia, which restores normal blood glucose levels to ensure sufficient provision of glucose to the brain, is critical for survival. To discover underlying brain regulatory systems, we performed a genetic screen in recombinant inbred mice for quantitative trait loci (QTL) controlling glucagon secretion in response to neuroglucopenia. We identified a QTL on the distal part of chromosome 7 and combined this genetic information with transcriptomic analysis of hypothalami. This revealed Fgf15 as the strongest candidate to control the glucagon response. Fgf15 was found to be expressed by neurons of the dorsomedial hypothalamus and the perifornical area. Intracerebroventricular injection of FGF19, the human ortholog of Fgf15, reduced activation by neuroglucopenia of dorsal vagal complex neurons and of the parasympathetic nerve, leading to a lower glucagon secretion. These data show that Fgf15 in hypothalamic neurons is a regulator of vagal nerve activity in response to neuroglucopenia.

2016-11-07 | GSE87586 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data